Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal dialysis solutions--at a crossroad.

J A Diaz-Buxo1, L Gotloib

  • 1Fresenius Medical Care North America, Home Therapies Development, Lexington, MA, USA. jose.diaz-buxo@fmc-na.com

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The continuum home program concept.

Clinical nephrology·2008
Same author

Prescription writing: CAPD and PD plus.

Clinical nephrology·2008
Same author

Definition of recurrent peritonitis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2007
Same author

The use of peritoneal mesothelium as a potential source of adult stem cells.

The International journal of artificial organs·2007
Same author

Complications of peritoneal dialysis catheters: early and late.

The International journal of artificial organs·2006
Same author

A short review of experimental peritoneal sclerosis: from mice to men.

The International journal of artificial organs·2005

Peritoneal dialysis fluids (PDF) face formulation challenges. Innovations like low glucose degradation product (GDP) solutions and antioxidants offer potential improvements for biocompatibility and preventing membrane failure.

Area of Science:

  • Nephrology
  • Biomaterials Science

Background:

  • Peritoneal dialysis fluids (PDF) have evolved significantly, presenting numerous formulation choices.
  • Current PDFs face challenges related to biocompatibility and inflammatory responses.

Purpose of the Study:

  • To review recent developments in PDF formulation.
  • To stimulate future research for improved PDF biocompatibility and efficacy.

Main Methods:

  • Review of existing literature, laboratory trials, and clinical evaluations.
  • Analysis of advancements in PDF composition, including osmotic agents and additives.
  • Exploration of novel therapeutic strategies for peritoneal membrane health.

Main Results:

  • The search for ideal biocompatible osmotic agents remains unsuccessful.

Related Experiment Videos

  • Research on inflammatory mediators provides insights but lacks targeted solutions.
  • Low glucose degradation product (GDP) solutions represent a significant advancement.
  • Antioxidants and mesothelial cell autotransplantation are promising areas for further investigation.

    • Conclusions:

    • PDF formulation is at a critical juncture with multiple avenues for improvement.
    • Low GDP solutions are a key development, but other factors like oxidative stress require attention.
    • Antioxidants and cell-based therapies hold potential for enhancing PDF biocompatibility and preventing membrane failure.